Semaglutide Injection is a once-weekly GLP-1 receptor agonist used to improve glycaemic control in adults with type 2 diabetes and to support weight management when indicated. It works by enhancing insulin release, reducing glucagon secretion, and slowing gastric emptying.

Key Benefits

• Improves blood glucose control in type 2 diabetes
• Supports clinically meaningful weight reduction when combined with diet and exercise
• Convenient once-weekly dosing via a prefilled pen

Composition

Active ingredient: Semaglutide.

How It Works

Acts as a GLP-1 receptor agonist to increase insulin secretion in a glucose-dependent manner, decrease glucagon, and slow gastric emptying, thereby reducing appetite.

Usage Directions

• Inject subcutaneously once weekly as prescribed by a healthcare professional.
• Rotate injection sites and follow the prescribing information for dose titration.

Possible Side Effects

• Nausea, vomiting, diarrhea
• Decreased appetite
• Occasional dizziness

Precautions

• Not indicated for type 1 diabetes or diabetic ketoacidosis.
• Use under medical supervision; monitor for gastrointestinal effects and kidney function in susceptible patients.

Storage Instructions

• Store refrigerated at 2°C–8°C until first use; after first use follow pen storage instructions.
• Do not freeze; protect from direct heat and sunlight.

Manufacturer

Novo Nordisk